Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IINN
IINN logo

IINN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Qtrex Quantum Ltd (IINN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
--
1 Day change
2.11%
52 Week Range
1.650
Analysis Updated At
2026/05/15
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

IINN is not a good buy right now for a beginner investor with a long-term focus and $50,000-$100,000 to deploy. The stock is in a weak pre-market position at 0.3967, below key resistance and near support, with bearish trend signals dominating. With no bullish proprietary signal, no recent news catalyst, neutral hedge fund and insider activity, and no financial snapshot to support a growth case, the setup does not justify an immediate purchase. Given the user's impatience and desire to act now, the direct answer is to avoid buying and wait.

Technical Analysis

Technical trend is bearish. MACD histogram is negative and still expanding downward, which signals weakening momentum. RSI_6 at 25.749 shows the stock is near oversold territory but not yet producing a clear reversal signal. The moving averages are stacked bearishly with SMA_200 > SMA_20 > SMA_5, confirming a downtrend. Current pre-market price 0.3967 is just above S1 at 0.394 and below pivot 0.435, which means price is trading under the main decision zone. Short-term pattern analysis also leans negative, with an estimated 80% chance of -0.86% next day and -2.35% next week, despite a modest 10.8% upside over the next month.

Positive Catalysts

  • No news in the recent week, so there are no identifiable event-driven bullish catalysts. The only mild positive is that price is near support at 0.394, which could attract value buyers, but there is no confirmed reversal signal.

Neutral/Negative Catalysts

  • Bearish technical structure, negative and widening MACD histogram, price below pivot, no recent news, no strong hedge fund or insider buying, no AI Stock Picker signal, no SwingMax signal, and no recent congress trading data. The broader pre-market tape is also weak with the S&P 500 down 1.03%.

Financial Performance

No usable latest-quarter financial snapshot was provided, so there is no verified quarterly revenue or earnings growth evidence to support a long-term buy case. As a result, the latest-quarter fundamental momentum cannot be assessed.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so Wall Street sentiment cannot be confirmed. Based on the available data, there is no evidence of improving analyst conviction, and the current setup looks weak rather than supported by bullish revisions.

Wall Street analysts forecast IINN stock price to rise
Analyst Rating
0
Wall Street analysts forecast IINN stock price to rise
Buy
Hold
Sell
0
Current: 0.380
sliders
Low
0
Averages
0
High
0
0
Current: 0.380
sliders
Low
0
Averages
0
High
0
Litchfield Hills
Theodore O'Neill
Buy
initiated
$2
AI Analysis
2025-06-02
Reason
Litchfield Hills
Theodore O'Neill
Price Target
$2
AI Analysis
2025-06-02
initiated
Buy
Reason
Litchfield Hills analyst Theodore O'Neill initiated coverage of Inspira Technologies with a Buy rating and $2 price target. Inspira is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions, the analyst tells investors in a research note. The firm says the company has a "well-protected technology moat" that includes both patented technology and technical trade secrets.

People Also Watch